⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Spanish Medical Record Review of Clinical Characteristics and Outcomes in Non-small Cell Lung Cancer Participants With EGFR Exon 20 Insertion

Official Title: Patient Characteristics, Treatment Patterns and Outcomes of Advanced Non-small Cell Lung Cancer Patients With EGFR Exon 20 Insertion Mutations: A Non-interventional Retrospective Medical Chart Review in Spain

Study ID: NCT05419700

Interventions

Study Description

Brief Summary: The main aim is to evaluate sociodemographic and clinical characteristics of advanced Non-Small Cell Lung Cancer (NSCLC) in adults participants with epidermal growth factor receptor (EGFR) exon 20 insertions mutations during the 5 years before data extraction date (from 1-Jan-2017 to 1-Jan-2022). Participants will not receive any drug. This study will only collect the data from the medical records via chart review.

Detailed Description: This is an observational, non-interventional, retrospective study in participants with NSCLC with EGFR exon 20 insertions mutations. This study will assess the sociodemographic and clinical characteristics of advanced NSCLC participants. The study will enroll approximately 60 participants. Participants who were evaluated and treated at the participating sites between 01 January 2017 and 30 September 2021 will be included. The data will be collected from the medical record of participants via medical chart review. All the participants will be assigned to a single observational cohort: • Participants With Advanced NSCLC with EGFR Exon 20 Insertions Mutations This multi-center trial will be conducted in Spain. The overall duration of the study will be approximately 27 months.

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Hospital Universitario Reina Sofia, Cordoba, Andalucia, Spain

Hospital Universitario Virgen de la Victoria, Malaga, Andalucia, Spain

Hospital Universitario Virgen del Rocio, Sevilla, Andalucia, Spain

ICO Badalona. Hospital Universitario Germans Trias i Pujol, Badalona, Cataluna, Spain

Hospital Clinicde Barcelona, Barcelona, Cataluna, Spain

Hospital de la Santa Creu i Sant Pau, Barcelona, Cataluna, Spain

ICO Girona. Hospital Universitario Dr. Josep Trueta, Gerona, Cataluna, Spain

Hospital Universitario Ramon y Cajal, Madrid, Comunidad De Madrid, Spain

Hospital Universitario 12 de Octubre, Madrid, Comunidad De Madrid, Spain

Hospital Universitario Puerta de Hierro, Madrid, Comunidad De Madrid, Spain

Hospital General Universitario de Alicante, Alicante, Comunidad Valenciana, Spain

Hospital Universitari i Politecnic la Fe, Valencia, Comunidad Valenciana, Spain

Complejo Hospitalario Universitario A Coruna (CHUAC), A Coruna, Galicia, Spain

Complejo Hospitalario Universitario de Santiago (CHUS), Santiago, Galicia, Spain

Hospital Universitario de Navarra (HUN), Pamplona, Navarra, Spain

Contact Details

Name: Study Director

Affiliation: Takeda

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: